Ernest Meštrović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ernest Meštrović has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Gordan Horvat
Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia
2 shared publications Josip Požar
Department of Chemistry Faculty of Science University of Zagreb Horvatovac 102a 10000 Zagreb Croatia
2 shared publications- Dejan-Krešimir Bučar
University College London
1 shared publication Dubravka Šišak Jung
DECTRIS Ltd. Taefernweg 1, 5405 Baden-Daettwil, Switzerland
1 shared publicationEdislav Lekšić
PLIVA Croatia, TAPI R&D, Prilaz Baruna Filipovića 25, HR-10000 Zagreb, Croatia
1 shared publication- Graeme Matthew Day
University of Southampton
1 shared publication
Latest Publications
- 12 June 2017
- Published by Wiley in ChemistrySelect
- Vol. 2 (17) , 4899-4905
Optimization of Omeprazole Synthesis: Physico‐Chemical Steering Towards Greener Processes
This work presents an optimization of the synthetic procedure for production of Omeprazole, a highly important pharmaceutical. The physico‐chemical measurements of the protonation and solution processes regarding the Omeprazole precursors aided the conception of the optimization strategy based primarily on the modifications of the reaction media. To this end, the protonation ( K H ) and solvation properties (solubilities, solution enthalpies, and entropies) of the starting materials and the intermediate were determined in different methanol/water mixtures and pure methanol, allowing the selection of the solvent optimal for the Omeprazole synthesis. In addition, it was proven that the energetically demanding refluxing procedure, which is conventionally used in the first step of the Omeprazol synthesis, was unnecessary. Similar holds for the time‐consuming trituration employed in the step involving precipitation of the final product. It was shown that trituration period can be significantly reduced without affecting the purity of the product. Taking into account the above‐mentioned findings, the improved procedure (compared to the standard one) for Omeprazol preparation was proposed. It was based on a greener process demanding less organic solvent, exhibiting enhanced energy‐ and time‐efficiency, which could be implemented in the large scale production. The concept devised in this work could easily be extended to other systems ameliorating the synthetic procedures of valuable drugs, rendering higher profit and lowering ecological risks.
- 12 June 2017
- Published by Wiley in ChemistrySelect
- Vol. 2 (17) , 4899-4905
Optimization of Omeprazole Synthesis: Physico‐Chemical Steering Towards Greener Processes
This work presents an optimization of the synthetic procedure for production of Omeprazole, a highly important pharmaceutical. The physico‐chemical measurements of the protonation and solution processes regarding the Omeprazole precursors aided the conception of the optimization strategy based primarily on the modifications of the reaction media. To this end, the protonation ( K H ) and solvation properties (solubilities, solution enthalpies, and entropies) of the starting materials and the intermediate were determined in different methanol/water mixtures and pure methanol, allowing the selection of the solvent optimal for the Omeprazole synthesis. In addition, it was proven that the energetically demanding refluxing procedure, which is conventionally used in the first step of the Omeprazol synthesis, was unnecessary. Similar holds for the time‐consuming trituration employed in the step involving precipitation of the final product. It was shown that trituration period can be significantly reduced without affecting the purity of the product. Taking into account the above‐mentioned findings, the improved procedure (compared to the standard one) for Omeprazol preparation was proposed. It was based on a greener process demanding less organic solvent, exhibiting enhanced energy‐ and time‐efficiency, which could be implemented in the large scale production. The concept devised in this work could easily be extended to other systems ameliorating the synthetic procedures of valuable drugs, rendering higher profit and lowering ecological risks.
- 26 April 2016
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 16 (6) , 3262-3270
Solid-State Chemistry and Polymorphism of the Nucleobase Adenine
- 26 April 2016
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 16 (6) , 3262-3270
Solid-State Chemistry and Polymorphism of the Nucleobase Adenine
- 9 October 2013
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 16 (1) , 32-35
A sildenafil cocrystal based on acetylsalicylic acid exhibits an enhanced intrinsic dissolution rate
Cocrystallisation of sildenafil with acetylsalicylic acid yields a 1 : 1 sildenafil–acetylsalicylic-acid cocrystal, as well as a 1 : 1 : 1 cocrystal salt involving a sildenafil cation, acetylsalicylate and salicylic acid. The 1 : 1 acetylsalicylic-acid-based cocrystal exhibits an enhanced intrinsic dissolution rate, as compared to sildenafil citrate (the active ingredient of Viagra®).
- 9 October 2013
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 16 (1) , 32-35
A sildenafil cocrystal based on acetylsalicylic acid exhibits an enhanced intrinsic dissolution rate
Cocrystallisation of sildenafil with acetylsalicylic acid yields a 1 : 1 sildenafil–acetylsalicylic-acid cocrystal, as well as a 1 : 1 : 1 cocrystal salt involving a sildenafil cation, acetylsalicylate and salicylic acid. The 1 : 1 acetylsalicylic-acid-based cocrystal exhibits an enhanced intrinsic dissolution rate, as compared to sildenafil citrate (the active ingredient of Viagra®).